A carregar...
Effect of the CYP3A inhibitors, diltiazem and ketoconazole, on ticagrelor pharmacokinetics in healthy volunteers
OBJECTIVES: Two open-label, two-period, crossover studies in healthy volunteers were designed to determine the pharmacokinetic interactions between ticagrelor, a P2Y(12) receptor antagonist, and a moderate (diltiazem) and a strong (ketoconazole) cytochrome P450 (CYP) 3A inhibitor. METHODS: Seventeen...
Na minha lista:
| Publicado no: | J Drug Assess |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Maney Publishing
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937655/ https://ncbi.nlm.nih.gov/pubmed/27536435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/21556660.2013.785413 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|